John Paul Mathias

This inventor holds 31 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: Pfizer Corporation, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc.. Active years: 2001-2023.

USPTO Granted Patents = 31 (Patent Applications = 1)

% Patents Active = 67.7

CIPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 362(Granted Patents)

Location History:

Ashford, GB (2009)
Sandwich, GB (2001 - 2011)
Concord, MA (US) (2016 - 2023)

Company Filing History:

Cystic Fibrosis Foundation

patents

3 out of 5

Cystic Fibrosis Foundation Therapeutics, Inc.

patents

Years Active: 2001-2023

Loading Chart...

Areas of Expertise:

Bicyclic-Fused Heteroaryl Compounds

CFTR Potentiators

IRAK4 Modulators

Heterocyclic Compounds

Vanin-1 Inhibitors

P38 MAP Kinase Inhibitors

Nicotinamide Derivatives

PDE4 Inhibitors

Quinazolinone Compounds

Pyrazolopyrimidinones

cGMP PDE5 Inhibitors

Pharmaceutically Active Compounds

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),

2. 10793579 - Bicyclic-fused heteroaryl or aryl compounds (2020-10-06),

3. 10766904 - Bicyclic heteroaryl derivatives as CFTR potentiators (2020-09-08),

4. 10494374 - Pyrrolopyrimidines as CFTR potentiators (2019-12-03),

5. 10377762 - Bicyclic heteroaryl derivatives as CFTR potentiators (2019-08-13),

6. 10329302 - Bicyclic-fused heteroaryl or aryl compounds (2019-06-25),

7. 10316018 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (2019-06-11),

8. 10308615 - Heterocyclic compounds as inhibitors of Vanin-1 enzyme (2019-06-04),

9. 10301315 - Pyrrolopyrimidines as CFTR potentiators (2019-05-28),

10. 10208053 - Bicyclic heteroaryl derivatives as CFTR potentiators (2019-02-19),

11. 10174000 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (2019-01-08),

12. 10131670 - Bicyclic heteroaryl derivatives as CFTR potentiators (2018-11-20),

13. 9879022 - Bicyclic-fused heteroaryl or aryl compounds (2018-01-30),

14. 9458168 - Bicyclic-fused heteroaryl or aryl compounds (2016-10-04),

15. 8076356 - Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors (2011-12-13),

Title: John Paul Mathias - Innovator from Sandwich, GB

Introduction: John Paul Mathias is a renowned inventor hailing from Sandwich, Great Britain, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: John Paul Mathias holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, John Paul Mathias has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, John Paul Mathias has collaborated with top scientists, engineers, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: John Paul Mathias continues to be a driving force in the world of technology and innovation, with his relentless pursuit of excellence and passion for creating solutions that make a difference.